Skip to main content
. Author manuscript; available in PMC: 2015 Jan 16.
Published in final edited form as: Vaccine. 2013 Nov 19;32(4):514–520. doi: 10.1016/j.vaccine.2013.11.020

Figure 2.

Figure 2

Effects of vaccination on the serotype specific incidence of dengue. Figure showing example output of the “base case” simulation, where all serotypes are equally transmissible, have an equal probability of leading to clinical disease and do not interact. In Panel A, vaccine efficacy against dengue 1–4 was assumed to be 0.8. In panel B, vaccine efficacy against DENV- 2 was reduced to 0.05. Solid regions indicate cases occurring in unvaccinated population and hatched region indicates those occurring in people who have received at least one vaccine dose.